Morgan Stanley analyst Dara Mohsenian maintains Clorox (NYSE:CLX) with a Underweight and lowers the price target from $160 to $154.
Zoom Says Aware Of Issues Currently Impacting Zoom; Engineering Team Is Investigating This Matter
https://twitter.com/Zoom/status/1570432770572263427